Article Text

Download PDFPDF

E-142 Efficacy and safety of mechanical thrombectomy using larger bore jet 7 aspiration catheters for intracranial large vessel occlusion
  1. A Hassan1,
  2. J Fifi2,
  3. O Zaidat3
  1. 1Valley Baptist Medical Center, Harlingen, TX
  2. 2The Mount Sinai Hospital, New York, NY
  3. 3Mercy Health St. Vincent Medical Center, Toledo, OH


Purpose To report initial experience of A Direct Aspiration first-Pass Thrombectomy (ADAPT) technique using larger bore JET 7 aspiration catheters in patients experiencing acute ischemic stroke secondary to intracranial large vessel occlusions (LVO).

Materials and methods COMPLETE is a prospective, single-arm, multi-center observational registry, including patients with intracranial LVO who are eligible for mechanical thrombectomy and have planned frontline treatment with Penumbra System. We performed an interim analysis in patients treated with new larger bore JET 7 aspiration catheters (inner diameter of 0.072’). Primary outcomes included angiographic revascularization of the occluded target vessel at immediate post-procedure as defined by an mTICI 2b or higher, functional outcome at 90 days post-procedure as defined by a mRS 0–2, and all-cause mortality at 90 days. Secondary outcomes included incidence of device- and procedure-related serious adverse events (SAEs), occurrence of embolization in previously uninvolved (or new) territories (ENT), and occurrence of symptomatic intracranial hemorrhages (sICH) at 24 hours.

Results Fifty-five patients (mean age 66.5 ± 13.0; 50.9% female) treated at 12 sites in the US were included in this analysis. Baseline NIHSS (mean ± SD) was 14.8 ± 7.3. Median ASPECT Score was 9.0 (IQR, 8.0–10.0). Target vessel location was the internal carotid artery or terminus in 18.2% (10/55), M1 in 52.7% (29/55), M2 in 16.4% (9/55), and posterior circulation in 12.7% (7/55) of patients. Median procedure time was 28.0 minutes (IQR, 16.0–50.0).

Successful revascularization (mTICI 2b or higher) was achieved in 92.6% (50/54) of patients. Good functional outcome (mRS 0–2) at 90 days was observed in 42.9% (6/14) of patients; follow-up data collection is ongoing. Mortality occurred in 10.9% (6/55) of patients. Procedure- and device-related SAEs occurred in 5.6% (3/54) and 1.9% (1/54) of patients, respectively. Vessel dissection was reported in 1.9% (1/54) of patients. There were no occurrences of sICH, ENT, or vessel perforation.

Conclusion In this initial experience, the safety and efficacy of Penumbra System with larger bore JET 7 aspiration catheters for patients with LVO is acceptable and comparable to other aspiration catheters. Use of larger bore aspiration catheters resulted in fast overall procedural time.

Disclosures A. Hassan: 1; C; Penumbra. 2; C; Penumbra, GE Healthcare, Medtronic, Stryker, MicroVention, Genentech. 3; C; Penumbra, GE Healthcare, Medtronic, Stryker, MicroVention, Genentech. J. Fifi: 1; C; Penumbra. 2; C; Penumbra. O. Zaidat: 1; C; Penumbra, Stryker, Genentech, Medtronic Neurovascular. 2; C; Penumbra, Medtronic Neurovascular, Codman, Stryker.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.